Theranostic Polyaminocarboxylate-Cyanine-Transferrin Conjugate for Anticancer Therapy and Near-Infrared Optical Imaging.
Theranostic Polyaminocarboxylate-Cyanine-Transferrin Conjugate for Anticancer Therapy and Near-Infrared Optical Imaging.
复制标题
用于抗癌治疗和近红外光学成像的治疗诊断聚氨基羧酸盐-花青-转铁蛋白缀合物。
DOI:
10.1002/cmdc.201600072
复制
发表时间:
2016-10-06
期刊:
影响因子:
3.4
通讯作者:
Chong, Hyun-Soon
中科院分区:
文献类型:
--
作者:
Kang, Chi Soo;Ren, Siyuan;Sun, Xiang;Chong, Hyun-Soon
Iron depletion using iron chelating agents has been recognized as a promising anti-tumor therapeutic strategy. We herein report a novel theranostic agent for targeted iron chelation cancer therapy and near IR optical imaging. The theranostic agent was prepared via incorporation of a polyaminocarboxylated-based cytotoxic chelating agent (N-NE3TA) and a near IR fluorescent cyanine dye (Cy5.5) into a tumor targeting transferrin. The cytotoxic chelating agent was conjugated to transferrin (Tf), and the corresponding NE3TA-Tf conjugate was characterized and evaluated for anti-proliferative activity in HeLa, HT29, and PC3 cancer cells with elevated expression of transferrin receptor (TfR). The NE3TA-Tf conjugate displayed significant inhibitory activity against cancer cells (HeLa, HT29, and PC3). The near IR dye Cy5.5 was loaded into the NE3TA-Tf platform, and the cytotoxic and fluorescent transferrin conjugate (N-NE3TA-Tf-Cy5.5) was microscopically shown to enter the TfR over-expressing cancer cells. The theranostic conjugate (N-NE3TA-Tf-Cy5.5) has a potential application for dual use in targeted iron chelation cancer therapy and near IR fluorescence (NIRF) imaging.
登录
查看更多内容
影响因子:
3.9
作者:
Kang, Chi Soo;Wu, Ningjie;Chong, Hyun-Soon
通讯作者:
Chong, Hyun-Soon
影响因子:
24.5
作者:
Brookes, M. J.;Hughes, S.;Tselepis, C.
通讯作者:
Tselepis, C.
影响因子:
6.6
作者:
KEER, HN;KOZLOWSKI, JM;GRAYHACK, JT
通讯作者:
GRAYHACK, JT
影响因子:
4.7
作者:
MUJUMDAR, RB;ERNST, LA;WAGGONER, AS
通讯作者:
WAGGONER, AS
影响因子:
4.9
作者:
Chong, Hyun-Soon;Song, Hyun A.;Mhaske, Santosh B.
通讯作者:
Mhaske, Santosh B.